Summary

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, Share, and Analysis, By Cardiac Monitoring Devices (Implantable Loop Recorder, ECG Devices, Event Monitors, Cardiac Output Monitoring), By Rhythm Management Devices (Defibrillators, Cardiac Resynchronization Therapy Devices, Pacemakers), By End-User (Hospitals, Home & Ambulatory Care, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034

PRODUCT OVERVIEW
Cardiac Monitoring & Cardiac Rhythm Management Devices Market is anticipated to exhibit a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 31.2 billion and is projected to reach USD 75.8 billion by the completion of 2034.
Cardiac monitoring refers to continuous observation and recording of the electrical activity and rhythm of the heart to detect irregularities and anomalies. It uses various devices such as electrocardiogram (ECG or EKG) monitors, along with Holter monitors and implantable loop recorders. These tools provide important data for diagnosing and managing heart conditions such as arrhythmias and heart block. In contrast, cardiac rhythm management devices are specially designed instruments, that are used to manage and treat abnormal heart rhythms. This category includes pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices. Pacemakers send electrical signals to manage heartbeats in individuals with slow heart rates and implantable cardioverter-defibrillators deliver shocks to restore normal rhythms during dangerous arrhythmias. Cardiac resynchronization therapy devices synchronize the contractions of heart chambers to improve pumping efficiency in patients with heart failure. Thus, cardiac monitoring and cardiac rhythm management devices are important for diagnosing and treating various cardiac conditions, which ultimately improves the quality of life of heart patients.

MARKET HIGHLIGHTS
Cardiac Monitoring & Cardiac Rhythm Management Devices Market is projected to reach USD 75.8 billion over the forecast period, due to several improvements in technology, such as reduction in the size of devices, along with wireless connectivity and data analytics. Alongside, the rising cases of cardiovascular diseases, such as heart rhythm disorders, are a major contributor to the growth of the cardiac monitoring & cardiac rhythm management devices market. In addition, demographic changes, like an aging population and lifestyle changes are leading to high heart-related ailments, that further boost the adoption of these devices. Furthermore, the adoption of remote monitoring solutions and telemedicine practices in the post-COVID-19 era is improving the penetration of heart monitoring and rhythm management devices within the market. Consequently, the cardiac monitoring & cardiac rhythm management devices market shows promising growth prospects owing to innovations and healthcare initiatives.

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Segments:

• By Cardiac Monitoring Devices
o Implantable Loop Recorder
o ECG Devices
o Event Monitors
o Cardiac Output Monitoring
• By Rhythm Management Devices
o Defibrillators
o Cardiac Resynchronization Therapy Devices
o Pacemakers
• By End-User
o Hospitals
o Home & Ambulatory Care
o Others

MARKET DYNAMICS
Growth Drivers
Innovations in Technology will Encourage Growth in the Cardiac Monitoring & Rhythm Management Devices Market
Increasing Prevalence of Cardiovascular Diseases Will Act as a Catalyst
Restraint
Cost Restraints in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market Will Impact the Growth

Key Players
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Biotronik SE & Co. KG
• Philips Healthcare
• General Electric Company
• St. Jude Medical, Inc.
• Siemens Healthineers AG
• Microport Scientific Corporation
• Hill-Rom Holdings, Inc.
• LivaNova PLC
• Edwards Lifesciences Corporation
• Nihon Kohden Corporation
• BioTelemetry, Inc.
• Cardiac Science Corporation
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:
• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1.Regional Market Share
1.2. Business Trends
1.3.Cardiac Monitoring & Cardiac Rhythm Management Devices Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2.Cardiac Monitoring & Cardiac Rhythm Management Devices Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Cardiac Monitoring & Cardiac Rhythm Management Devices Market – Industry Insights
4.1.Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7.Market Dynamics
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. Cardiac Monitoring & Cardiac Rhythm Management Devices Market
10.1.Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecast 2024A-2034F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Cardiac Monitoring Devices
11.3.1.1. Implantable Loop Recorder
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2.Market Share (%) 2024-2034F
11.3.1.1.3.Y-o-Y Growth (%) 2024-2034F
11.3.1.2.ECG Monitors
11.3.1.2.1.By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3.Event Monitors
11.3.1.3.1.By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.4.Cardiac Output Monitoring
11.3.1.4.1.By Value (USD Million) 2024-2034F
11.3.1.4.2. Market Share (%) 2024-2034F
11.3.1.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Rhythm Management Devices
11.3.2.1.Defibrillators
11.3.2.1.1.By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Cardiac Resynchronization Therapy Devices
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2.Market Share (%) 2024-2034F
11.3.2.2.3.Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Pacemakers
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2.Market Share (%) 2024-2034F
11.3.2.3.3.Y-o-Y Growth (%) 2024-2034F
11.3.3. By End-User
11.3.3.1.Hospitals
11.3.3.1.1.By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Home & Ambulatory Care
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2.Market Share (%) 2024-2034F
11.3.3.2.3.Y-o-Y Growth (%) 2024-2034F
12. North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Cardiac Monitoring Devices
12.3.2.By Rhythm Management Devices
12.3.3.End-User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. Europe Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Cardiac Monitoring Devices
13.3.2.By Rhythm Management Devices
13.3.3.End-User
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecast 2024A-2034F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Cardiac Monitoring Devices
14.3.2.By Rhythm Management Devices
14.3.3.End-User
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecast 2024A-2034F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Cardiac Monitoring Devices
15.3.2.By Rhythm Management Devices
15.3.3.End-User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4.South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Cardiac Monitoring Devices
16.3.2.By Rhythm Management Devices
16.3.3.End-User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2.Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Medtronic plc
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Abbott Laboratories
18.3.Boston Scientific Corporation
18.4.Biotronik SE & Co. KG
18.5.Philips Healthcare
18.6.General Electric Company
18.7.St. Jude Medical, Inc.
18.8.Siemens Healthineers AG
18.9.Microport Scientific Corporation
18.10.Hill-Rom Holdings, Inc.
18.11. LivaNova PLC
18.12.Edwards Lifesciences Corporation
18.13.Nihon Kohden Corporation
18.14.BioTelemetry, Inc.
18.15.Cardiac Science Corporation
18.16.Other Prominent Players
19. Appendix
20.Consultant Recommendation